Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMITRIPTYLINE vs AMIVANTAMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMITRIPTYLINE vs AMIVANTAMAB: Safety Overview

Metric AMITRIPTYLINE AMIVANTAMAB
Total FAERS Reports 20,382 748
Deaths Reported 4,837 116
Death Rate 23.7% 15.5%
Hospitalizations 7,290 445
Average Patient Age 55.2 yrs 63.5 yrs
% Female Patients 70.9% 65.3%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Proficient Rx LP Janssen Biotech, Inc.
Route ORAL INTRAVENOUS
Marketing Status Discontinued N/A